PharmaShots | Incisive News in 3 Shots

Subscribe Now

renalys pharma

Renalys Pharma’s Sparsentan Secures the MHLW’s Orphan Drug Designation to Treat Primary IgA Nephropathy

Renalys Pharma’s Sparsentan Secures the MHLW’s Orphan Drug Designation to Treat Primary IgA Nephropathy

December 2, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us